The effects of intravenous granisetron on the sensory and motor blockade produced by intrathecal bupivacaine

Anesthesia and Analgesia

Volumn 106, Issue 4, 2008, Pages 1322-1325

  Mowafi, Hany A ^a,b   Arab, Samer A ^a   Ismail, Salah A ^a   Al Ghamdi, Abdulmohsin ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; GRANISETRON; SEROTONIN 3 RECEPTOR; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEMODYNAMICS; HUMAN; KNEE ARTHROSCOPY; MALE; NERVE BLOCK; OPERATING ROOM; PRIORITY JOURNAL; SENSORY NERVE; SPINAL ANESTHESIA;

EID: 41349098414     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318165e012     Document Type: Article

References (23)

1. Van Wijngaarden I, Tulp MT, Soudijn W. The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 1990;138:301-12
2. 3 receptor antagonists for postoperative nausea and vomiting: are they all the same? CNS Drugs 2005;19:225-38
3. Aapro M. Granisetron: an update on its clinical use in the management of nausea and vomiting. Oncologist 2004;9:673-86
4. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacology 1994;33:275-317
5. 3 receptor mediation of pain and anti-nociception: implications for clinical therapeutics. Pain Physician 2004;7:141-7
6. Xu W, Qiu XC, Han JS. Serotonin receptor subtypes in spinal antinociception in the rat. J Pharmacol Exp Ther 1994;269:1182-9
7. Eide PK, Hole K. The role of 5-hydroxytryptamine (5-HT) receptor subtypes and plasticity in the 5-HT systems in the regulation of nociceptive sensitivity. Cephalalgia 1993;13:75-85
8. Bardin L, Lavarenne J, Eschalier A. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats. Pain 2000;86:11-18
9. 3 receptor antagonist. Neurosci Lett 1988;95:313-7
10. Naesh O, Hindberg I, Christiansen C. Subarachnoid bupivacaine increases human cerebrospinal fluid concentration of serotonin. Reg Anesth 1996;21:446-50
11. Fassoulaki A, Melemeni A, Zotou M, Sarantopoulos C. Systemic ondansetron antagonizes the sensory block produced by intrathecal lidocaine. Anesth Analg 2005;100:1817-21
12. Martin-Salvaj G, Van Gessel E, Forster A, Schweizer A, Iselin-Chaves I, Gamulin Z. Influence of duration of lateral decubitus on the spread of hyperbaric tetracaine during spinal anesthesia: a prospective time-response study. Anesth Analg 1994;79:1107-12
13. 3 spinal receptor involvement in acute pain in humans. Anesth Analg 2002;94:1553-7
14. 3 receptor antagonists in three pain tests. Neuropharmacology 1989;28:431-4
15. Blower P. A pharmacologic profile of oral granisetron (Kytril tablets). Semin Oncol 1995;22(suppl 10):3-5
16. Yoshimura M, Furue H. Mechanisms for the antinociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci 2006;101:107-17
17. Lopes-Garcia JA. Serotonergic modulation of spinal sensory circuits. Curr Top Med Chem 2006;6:1987-96
18. Ernberg M, Lundeberg T, Kopp S. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia. Pain 2003;101:275-82
19. 3 receptor antagonists. Scand J Rheumatol 2004;33:19-23
20. 3 receptor antagonists replace anesthetics and corticosteroids in the local treatment of rheumatic processes? Curr Rheumatol Review 2005;1:295-8
21. Fujii Y, Tanaka H. Efficacy of granisetron for the treatment of postoperative nausea and vomiting in women undergoing breast surgery: a randomised, double-blind, placebo-controlled trial. Clin Drug Investig 2006;26:203-8
22. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, Kovac A, Philip BK, Sessler DI, Temo J, Tramèr MR, Watcha M. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71
23. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: a review. Can J Anaesth 2004;51:326-41